A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
Clinical trial NCT05599191 · COMPLETED
Trial details
- NCT number
- NCT05599191
- Sponsor
- Bellus Health Inc. - a GSK company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-25
- Primary completion
- 2025-12-17
- Enrollment
- 957
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.